PI Data Hub
News wire
Recalls, rulings, MDL activity and bar news from official publishers and legal outlets. Every headline is the publisher’s own and links to it; every tag shows the words that earned it.
Checked 3 min ago · 81 of 90 sources responding · Sources and method
Sildenafil and Tadalafil are active ingredients in FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a licensed health care professional. These undeclared ingredients ma
Clermont, Florida – A&P Creations LLC is recalling X10 Natural Enhancement Supplement to the consumer level because it has been found to contain undeclared sildenafil and tadalafil.
Being a good lawyer takes more than sound advice and clear communication. People also need to know who you are, what you do, and how you can help. That means marketing, whether you enjoy it or not. The good news is that marketing does not have to become a second job. With a focused plan and the right AI tools,... The post Practical Strategies and Tools for Lawyers to Use AI for Marketing first appeared on North Carolina Bar Association .
The new issue of Bar News celebrates the APEX Awards, honoring outstanding professionals across 11 categories. This issue also features stories of impactful individuals, discussions on public defense challenges, and covers key legal updates, including new probate laws and insights on legal citation and practice management.
By Tom Jarvis Judge Joseph Laplante of the US District Court for the District of New Hampshire will receive the 2026 Frank Rowe Kenison Award at the New Hampshire Bar Foundation’s Annual Dinner on Wednesday, October 21, at Pembroke Pines Country Club in Pembroke. The Bar Foundation presents the Kenison Award annually to recognize substantial ... Read more The post Judge Joseph Laplante to Receive Kenison Award at Bar Foundation Annual Dinner appeared first on NHBA .
By Tom Jarvis The New Hampshire Bar Association will bring attorneys, judges, educators, and other members of the legal community together on November 6 at the University of New Hampshire Franklin Pierce School of Law for “Counsel for the Future: Building a Foundation for Practice Readiness,” a symposium focused on mentorship and preparing the next ... Read more The post NHBA Symposium to Focus on Practice Readiness, Mentorship appeared first on NHBA .
By Tom Jarvis In a historic jury verdict, William Kelly became the first person in New Hampshire to be convicted under the state’s 2018 fetal homicide law. A Carroll County Superior Court jury convicted Kelly, 40, on July 9 of two counts of second-degree murder for the December 17, 2023, deaths of his girlfriend, Christine ... Read more The post Kelly Conviction Marks First Under New Hampshire Fetal Homicide Law appeared first on NHBA .
Please click on the image to access the full .pdf version of the Bar News. The post Bar News September 16, 2026 appeared first on NHBA .
Celebrate the 250th Anniversary of the Declaration of Independence on October 2, 2026 at the Chittenden Superior Civil Courthouse. More more information, visit HERE.
KEASBEY, N.J. (Sept. 14, 2026) –Wakefern Food Corp. has voluntarily recalled select containers of Wholesome Pantry Organic Unsweetened Apple Sauce after routine FDA testing identified elevated patulin levels that exceed food safety limits and do not meet Wakefern's quality standards
Whole Foods Market of Austin, TX is recalling Fromagerie Coop de Mean Cabricharme cheese because the product contains egg lysozyme, an egg white protein, which is not declared on the product label. People who have an allergy or severe sensitivity to eggs run the risk of a serious or life-threateni
FOR IMMEDIATE RELEASE – 9/9/2026 – Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer’s Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endot
Summaries are not part of the opinions of the Court. They have been prepared for the convenience of the reader and should not be quoted or cited.
News Date: Friday, September 11, 2026 - 14:30
General Motors, LLC (GM) has determined that certain model year (MY) 2024 Cadillac XT4, Chevrolet Colorado, and GMC Canyon motor vehicles do not fully comply with Federal Motor Vehicle Safety Standard (FMVSS) No. 108, Lamps, Reflective Devices, and Associated Equipment. GM filed a noncompliance report dated April 25, 2024, and subsequently petitioned NHTSA (the "Agency") on May 17, 2024, for a decision that the subject noncompliance is inconsequential as it relates to motor vehicle safety. This document announces receipt of GM's petition.
The Food and Drug Administration (FDA) is classifying the cardiovascular machine learning-based notification software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cardiovascular machine learning- based notification software. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access…
The NTSB announces the availability of the following publication: "NTSB FY 2026-2030 Strategic Plan".
09/10/2026, Evergreen Fresh Sprouts LLC of Moyie Springs, IDAHO is recalling 215 cases (6/4oz bags per case) of Broccoli Sprouts, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly pe
State Bar Seizes Chula Vista Immigration Consultant’s Unauthorized Law Practice Unauthorized Practice of Law Consumer Protection Cheryl.Cheng@c… Thu, 09/10/2026 - 10:19 Thu, Sep 10, 2026, All day The State Bar of California announced today the seizure of the unauthorized law practice of Gabriel Luna de la Fuente of Chula Vista, after he took more than $4,000 from a client for immigration services for herself and her daughter—selecting and preparing her legal forms himself, directing her to deposit money directly into his bank account, and never disclosing that he was not and never has been a…
By Julie Bays, OBA Practice Management Advisor Just when you thought there couldn’t possibly be another legal AI product to keep track of, Google has entered the legal AI market. […]
Damien de Loyola, a district defender in Kansas City, received the 2026 Defender of Distinction Award from the Missouri State Public Defender Commission. De Loyola is the district defender for Area 69, one of the Missouri State Public Defender appellate/post-conviction offices in Kansas City. He graduated from the University of Missouri-Kansas City School of Law and has been a public defender since 2012. De Loyola previously received The Missouri Bar Foundation’s David J. Dixon Appellate Advocacy Award and was a member of the 2015-2016 Missouri Bar Leadership Academy. He is a member of the…
Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
FMCSA announces receipt of applications from seven individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to control a commercial motor vehicle (CMV) to drive in interstate commerce. If granted, the exemptions would enable these individuals who have had one or more seizures and are taking anti-seizure medication to operate CMVs in interstate commerce.
FMCSA announces its decision to renew exemptions for nine individuals from the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have "no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV." The exemptions enable these individuals who have had one or more seizures and are taking anti-seizure medication to continue to operate CMVs in interstate commerce.
The Food and Drug Administration (FDA) is classifying the cooperative powered surgical assist device for ear, nose, and throat (ENT) surgery into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cooperative powered surgical assist device for ENT surgery. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also…
The Food and Drug Administration (FDA) is classifying the temperature regulation device for esophageal protection during cardiac ablation procedures into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the temperature regulation device for esophageal protection during cardiac ablation procedures. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the…
The Food and Drug Administration (FDA) is classifying the implanted tibial electrical urinary continence device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the implanted tibial electrical urinary continence device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial…
The Food and Drug Administration (FDA) is classifying the anti-tumor necrosis factor alpha monoclonal antibody test system for inflammatory bowel disease into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the anti-tumor necrosis factor alpha monoclonal antibody test system for inflammatory bowel disease. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of…